GFAP and Alzheimer disease: Glial fibrillary acidic protein (GFAP), neurofilament light (NFL), and triggering receptor expressed on myeloid cells 2 (TREM-2) are examples of biomarkers that have been reported in AD, mainly for their biological functions in the CNS.